Cardiovascular diseases in kidney transplant recipients: The role of anemia

被引:7
作者
Kadambi, PV [1 ]
Javaid, B [1 ]
机构
[1] Univ Chicago, Dept Med, Nephrol Sect, Pritzker Sch Med, Chicago, IL 60637 USA
关键词
kidney transplantation; anemia; cardiovascular diseases; ischemic heart disease; congestive heart failure;
D O I
10.1053/j.arrt.2004.04.003
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Cardiovascular diseases are among the leading causes of mortality and death associated graft loss in kidney transplant recipients. Recently, there has been an increased awareness of the potential role of nontraditional risk factors such as anemia in contributing to the increased burden of cardiovascular diseases in kidney transplant recipients. Studies that are primarily based on retrospective data analyses have shown an association between anemia and cardiovascular outcomes. These findings underscore the need for prospective studies to better understand these risks and to implement management strategies that would have a positive impact on patient and graft outcomes. On the basis of the available data, this article reviews the magnitude of cardiovascular diseases and anemia in kidney transplant recipients with a focus on the role of anemia on cardiovascular outcomes in these patients. (C) 2004 by the National Kidney Foundation, Inc.
引用
收藏
页码:328 / 333
页数:6
相关论文
共 25 条
[1]   Graft loss and acute coronary syndromes after renal transplantation in the United States [J].
Abbott, KC ;
Bucci, JR ;
Cruess, D ;
Taylor, AJ ;
Agodoa, LYC .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 (10) :2560-2569
[2]   Hospitalized congestive heart failure after renal transplantation in the United States [J].
Abbott, KC ;
Hypolite, IO ;
Hshieh, P ;
Cruess, D ;
Taylor, AJ ;
Agodoa, LY .
ANNALS OF EPIDEMIOLOGY, 2002, 12 (02) :115-122
[3]   Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction [J].
Al-Ahmad, A ;
Rand, WM ;
Manjunath, G ;
Konstam, MA ;
Salem, DN ;
Levey, AS ;
Sarnak, MJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 38 (04) :955-962
[4]   The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin [J].
Besarab, A ;
Bolton, WK ;
Browne, JK ;
Egrie, JC ;
Nissenson, AR ;
Okamoto, DM ;
Schwab, SJ ;
Goodkin, DA .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (09) :584-590
[5]  
Collins AJ, 2003, NEPHROL DIAL TRANSPL, V18, P2, DOI 10.1093/ndt/gfg1058
[6]   Increasing hematocrit reduces early posttransplant cardiovascular risk in diabetic transplant recipients. [J].
Djamali, A ;
Becker, YT ;
Simmons, WD ;
Johnson, CA ;
Premasathian, N ;
Becker, BN .
TRANSPLANTATION, 2003, 76 (05) :816-820
[7]   Progress in the treatment of rheumatic disease [J].
Gause, A .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2003, 18 (01) :13-16
[8]   Chronic kidney disease and the transplant recipient [J].
Gill, JS ;
Pereira, BJG .
BLOOD PURIFICATION, 2003, 21 (01) :137-142
[9]   Improved graft survival after renal transplantation in the United States, 1988 to 1996. [J].
Hariharan, S ;
Johnson, CP ;
Bresnahan, BA ;
Taranto, SE ;
McIntosh, MJ ;
Stablein, D .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (09) :605-612
[10]   The burden of chronic kidney disease in renal transplant recipients [J].
Karthikeyan, V ;
Karpinski, J ;
Nair, RC ;
Knoll, G .
AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 (02) :262-269